Connect with us

Business

After Admitting Mistake, AstraZeneca Faces Difficult Questions About Its Vaccine – The New York Times

Some trial participants only got a partial dose of AstraZeneca’s vaccine. Experts said the company’s spotty disclosures have eroded confidence.

Published

on

post featured image
ADVERTISEMENT

Bigger problems soon surfaced.
An AstraZeneca executive told Reuters on Monday that the company had not intended for any participants to receive the half dose. British researchers running the trial there had meant to give the full dose initially to volunteers, but a miscalculation meant they were mistakenly given only a half dose. The executive, Menelas Pangalos, described the error as serendipity, allowing researchers to stumble onto a more promising dosing regimen.
To many outside experts, that…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
What is a COVID-19 vaccine card, and do you need to keep it? – Salon
post featured image
3 Top E-Commerce Stocks for 2021 – The Motley Fool
post featured image
Parler CEO: ‘No indication’ Big Tech shutdown threats were ‘deadly serious’ until last minute – Fox News